RSS   Newsletter   Contact   Advertise with us
Post Online Media

Mersana Therapeutics appoints Andrew A. F. Hack to board

Mersana TherapeuticsMersana Therapeutics, a biotechnology company, announced the appointment of Andrew A. F. Hack to its board of directors.

Dr. Hack currently serves as Chief Financial Officer at Editas Medicine; a position he has held since 2015.

Dr. Hack served as a portfolio manager at Millennium Management, managing a healthcare investment fund focused on biotechnology, pharmaceutical, and medical device companies.

Prior to Millennium, he was a securities analyst at HealthCor Management, Carlyle-Blue Wave Partners, and the MPM BioEquities Fund. He started his investment career covering the biotechnology sector at Banc of America Securities.

In addition, Dr. Hack was a co-founder of Reify Corporation, a life science tools and drug discovery company.

Dr. Hack received his B.A. in biology with special honors from the University of Chicago, where he also received his M.D. and Ph.D., was named the inaugural Frank Family Scholar, and received awards from the American Heart Association and the American Society for Cell Biology.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy